Hosted on MSN

HIV Drugs Dramatically Lower Risk of Alzheimer's Disease, Study Finds

Scientists have identified a promising new class of treatments for Alzheimer's disease, and they're already widely used to treat HIV and hepatitis B. Along with their antiretroviral effects, drugs ...
Business Wire

LEO Pharma Presents Late-Breaking Results from the Phase 2a Mechanism of Action Trial of Temtokibart and Dupilumab in Moderate-to-Severe Atopic Dermatitis at the 2024 EADV ...

BALLERUP, Denmark--(BUSINESS WIRE)--NOT FOR UK USE – NOT INTENDED FOR UK MEDIA LEO Pharma A/S, a global leader in medical dermatology, today announced positive results from the Phase 2a Mechanism of ...
Hosted on MSN

HIV drugs offer 'substantial' Alzheimer's protection, new research suggests

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are substantially ...
Business Wire

Inflammasome Therapeutics Completes Enrollment in Study for First Oral Dual Inflammasome Inhibitor for Ophthalmic and Neuroinflammatory Diseases

NEWTON, Mass.--(BUSINESS WIRE)--Inflammasome Therapeutics, a private company, has completed enrollment of a Phase I PK/Safety study of its new brain- and retina-penetrant drug K9, which has ...